Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The renal cell carcinoma trial record is now displayed, with details on pembrolizumab versus placebo, participant eligibility, study measures, locations, and publications.
    Difference
    100%
    Check dated 2026-11-07T15:16:13.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:42:09.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:44:50.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T17:24:17.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T18:52:33.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, replacing the expected study record content. This blocks access to the trial details and related navigation.
    Difference
    17%
    Check dated 2026-09-19T22:21:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.